Literature DB >> 22939063

Pharmacoresistance.

Heidrun Potschka1, Martin J Brodie.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22939063     DOI： 10.1016/B978-0-444-52899-5.00025-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  4 in total

1.  Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis.

Authors:  Jan Henje Döring; Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

Review 2.  Pharmacogenomics in epilepsy.

Authors:  Simona Balestrini; Sanjay M Sisodiya
Journal:  Neurosci Lett       Date:  2017-01-10       Impact factor: 3.046

3.  ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population.

Authors:  Malek Chouchi; Hedia Klaa; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  Dis Markers       Date:  2019-12-02       Impact factor: 3.434

4.  Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis.

Authors:  Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.